Frontlight ResearchEarly access
WithdrawnNo phase
Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Sept 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Treatments tested
- Computed tomography coronary angiogram
- Record updated
- 6 March 2025
- Why it stopped
- Insufficient funding
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- All consecutive patients on record who underwent coronary artery bypass graft surgery in 2007 and 2008
Who cannot take part
- Concomitant valve and aortic procedures
- Concomitant repair of post-infarct ventricular septal rupture
- Intermediate to high risk for contrast nephropathy, defined as estimated glomerular filtration rate less than 45 ml/min/1.73m2 or serum creatinine level <1.5 mg/dL (based on American College of Radiology criteria for diagnostic computed tomography risk)
- Death
- Single vessel LIMA-LAD anastomosis only
- Defaulted follow-up
- Informed consent cannot be obtained
- Pregnancy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This single-centre cross-sectional study aims to ascertain the impact of dyslipidemia on long-term graft patency after coronary artery bypass grafting (CABG).
Treatments tested
- Computed tomography coronary angiogram
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Cholesterol Level on Long-term Angiographic Outcome of Coronary Artery Bypass Grafting
- Record updated
- 6 March 2025